Investment Management Corp Of Ontario Alnylam Pharmaceuticals, Inc. Transaction History
Investment Management Corp Of Ontario
- $3.57 Billion
- Q2 2024
A detailed history of Investment Management Corp Of Ontario transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Investment Management Corp Of Ontario holds 2,785 shares of ALNY stock, worth $768,827. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,785
Previous 1,985
40.3%
Holding current value
$768,827
Previous $296,000
128.38%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ALNY
# of Institutions
614Shares Held
108MCall Options Held
2.33MPut Options Held
2.17M-
Capital World Investors Los Angeles, CA15MShares$4.13 Billion0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$3.45 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.64 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.71 Billion0.28% of portfolio
-
Baillie Gifford & CO6.03MShares$1.67 Billion1.16% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $34B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...